CDK8 logo
CDK8 (Cyclin-dependent kinase 8)
FEATURES
Loading...
Loading...
FAMILY
DESCRIPTION
Also known as CDK8_HUMAN, CDK8. Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Phosphorylates the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAp II), which may inhibit the formation of a transcription initiation complex. Phosphorylates CCNH leading to down-regulation of the TFIIH complex and transcriptional repression. Recruited through interaction with MAML1 to hyperphosphorylate the intracellular domain of NOTCH, leading to its degradation. Component of the Mediator complex, which is composed of MED1, MED4, MED6, MED7, MED8, MED9, MED10, MED11, MED12, MED13, MED13L, MED14, MED15, MED16, MED17, MED18, MED19, MED20, MED21, MED22, MED23, MED24, MED25, MED26, MED27, MED29, MED30, MED31, CCNC, CDK8 and CDC2L6/CDK11. The MED12, MED13, CCNC and CDK8 subunits form a distinct module termed the CDK8 module. Mediator containing the CDK8 module is less active than Mediator lacking this module in supporting transcriptional activation. Individual preparations of the Mediator complex lacking one or more distinct subunits have been variously termed ARC, CRSP, DRIP, PC2, SMCC and TRAP. The cylin/CDK pair formed by CCNC/CDK8 also associates with the large subunit of RNA polymerase II. Interacts with CTNNB1, GLI3 and MAML1.
Also known as CDK8_HUMAN, CDK8. Component of the Mediator complex, a coactivator involved in regulated gene transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promot ...
CDK8 logo

CDK8

Cyclin-dependent kinase 8

Expression

StudyTumor samplesMaxQ3Q2Q1MinNormal samplesMaxQ3Q2Q1MinLog2 (T vs N)
Adrenocortical (ACC) 77 2.28 1.80 1.66 1.54 1.29 126 1.93 1.53 1.46 1.42 -0.09 0.20
Bladder (BLCA) 406 2.07 1.69 1.62 1.54 1.17 9 1.88 1.76 1.70 1.52 1.44 -0.08
Breast (BRCA) 1067 2.07 1.54 1.44 1.35 0.86 178 1.58 1.39 1.35 1.30 1.11 0.09
Cervical (CESC) 297 1.97 1.63 1.55 1.46 1.04 10 1.45 1.45 1.39 1.39 1.28 0.16
Cholangiocarcinoma (CHOL) 36 1.78 1.53 1.44 1.31 1.23 0
Colon (COAD) 443 2.37 1.94 1.84 1.74 1.35 166 2.41 1.71 1.58 1.53 -0.09 0.26
B-cell lymphoma (DLBC) 42 1.77 1.62 1.48 1.42 1.15 337 1.77 1.33 1.23 1.09 0.39 0.25
Esophageal (ESCA) 142 1.99 1.64 1.53 1.45 1.26 271 1.73 1.53 1.50 1.46 -0.09 0.03
Glioblastoma (GBM) 160 1.93 1.53 1.45 1.38 1.22 214 1.86 1.66 1.61 1.57 -0.09 -0.16
Head and neck (HNSC) 432 2.07 1.66 1.59 1.49 1.16 55 1.56 1.40 1.36 1.31 1.19 0.22